Late Effects of Treatment for Early-Stage Hodgkin's Disease
Author Information
Author(s): JD Brierley, AJ Rathmell, MK Gospodarowicz, SB Sutcliffe, A Munro, R Tsang, M Pintilie
Primary Institution: University of Toronto, Department of Radiation Oncology
Hypothesis
What are the late effects of treatment for early-stage Hodgkin's disease?
Conclusion
Patients treated for early-stage Hodgkin's disease experience significant late effects, including increased risks of second malignancies and heart disease.
Supporting Evidence
- Twenty patients died of second malignancy, 14 of heart disease, and nine from respiratory disease.
- The 15-year incidence of heart disease was 11%.
- 37 cases of second malignancy were reported with a relative risk of 2.2.
- 56 men fathered 112 pregnancies, and 40.3% of women became pregnant post-treatment.
Takeaway
This study looked at how people felt after being treated for Hodgkin's disease a long time ago, finding that many had health problems later on.
Methodology
Patients treated for early-stage Hodgkin's disease were surveyed about their health and quality of life after treatment.
Potential Biases
Potential bias due to self-reporting and loss to follow-up.
Limitations
The study is limited by its retrospective nature and the reliance on self-reported data.
Participant Demographics
The study included 611 patients (332 men, 279 women) with a median age of 31 years at diagnosis.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 1.57-3.08
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website